DesignPreclinical reproductive-aging study using aged female mice, oocyte assays and NAD-repletion interventions
PopulationAged female mice and oocytes
SampleMultiple animal and oocyte cohorts; see publication
InterventionNAD+ repletion strategies including NMN supplementation in reproductive-aging models
EndpointsOocyte NAD+; Oocyte quality and maturation; Fertility and reproductive outcomes; Mitochondrial and cellular mechanisms
What the publication reported
This study investigated whether age-related declines in NAD+ contribute to reduced female fertility in mice and whether restoring NAD+ can improve reproductive outcomes.
NMN and related NAD-repletion experiments improved several oocyte and fertility-related outcomes in aged mice, supporting a role for NAD metabolism in reproductive aging.
The work is influential mechanistic evidence, but it does not establish that NMN improves fertility, egg quality or reproductive outcomes in women.
Key findings
Reproductive aging in the mouse model was associated with declining NAD+ biology.
NAD+ repletion, including NMN-based experiments, improved oocyte-related outcomes.
Fertility-related measures improved in aged mice under specific experimental conditions.
The study identified cellular and mitochondrial mechanisms linked to reproductive aging.
What it cannot establish
Animal reproductive-aging study.
Mouse fertility biology and dosing cannot be directly extrapolated to women.
Multiple NAD-repletion approaches were studied, so findings are not all uniquely attributable to routine oral NMN supplementation.
No human fertility trial was performed.
HealthspanX claim boundary: This study does not establish that NMN improves fertility, egg quality, ovarian reserve or pregnancy outcomes in women.
